Purchase Order 75F40125P00213

Award Date 9/4/25
Potential Completion Date 9/7/26
Potential Value $100K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $32,190 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business. The contract is for testing and sequencing services, including RNA sequencing (bulk and single-cell), DNA sequencing, whole genome/exome sequencing, and metagenomics sequencing, as well as associated...
This $14,355.00 firm fixed price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business based in Fremont, California. The contract is for 76 samples for RNA sequencing services, with a period of performance through October 18, 2025. Seqmatic, LLC specializes in genomics and bioinformatics services, and has secured numerous federal contract awards from civilian...
This federal contract award from the Southeast Area of a civilian agency is for GENOME SEQUENCING SERVICE (RNASEQ) to be provided by Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business in Fremont, California. The $13,710 firm fixed-price purchase order has a performance period through December 5, 2024. Seqmatic is an experienced federal contractor, having secured numerous genome sequencing and bioinformatics services contracts with agencies such as the National...
This is a $44,520 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business located in Fremont, California. The contract is for whole exome sequencing (WES) of 95 genomic DNA samples derived from acute liver failure patients. This work is being performed under a total small business set-aside. Seqmatic, LLC is a provider of advanced genomics and bioinformatics services, and has secured...
This is a $49,044.00 firm fixed-price purchase order awarded to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business, by the Central Program Planning Coordination and Support (VPARSCPPCS-A) division of the U.S. government's civilian agency. The contract is for RNA sequencing services and has a period of performance ending on March 31, 2025. Seqmatic provides genomics and bioinformatics services to various federal agencies, including the USDA, NIH, CDC, FDA, NOAA, and...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm fixed-price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, to provide an Illumina MiniSeq DNA/RNA Next Generation Sequencer (NGS) device plus four years of post-warranty maintenance support. The total potential value of the contract is $86,106.00. This procurement was not set-aside for any particular business size or type. The contract...
Seqmatic, LLC has been awarded a $32,485 firm fixed price purchase order by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to provide single nuclei RNA sequencing sample testing services. As a minority-owned and Asian-Pacific American owned small business, Seqmatic will leverage over 10 years of experience in next generation sequencing, single cell analysis, library preparation, and bioinformatics to deliver the...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Novogene Corporation Inc., a minority-owned small business based in Sacramento, California. The contract, valued at $14,925.00, is for human messenger RNA (mRNA) sequencing services. The contract has an ultimate completion date of December 4, 2020 and was awarded on June 26, 2019. Novogene is a provider of advanced genomic sequencing and bioinformatics services, and has secured multiple...
The U.S. Centers for Disease Control and Prevention (CDC) has awarded a $167,175 firm fixed-price purchase order to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business based in Fremont, California. The contract is for SARS-CoV-2 next-generation sequencing services to support the CDC's infectious disease monitoring efforts. Seqmatic has established itself as a provider of genomics and bioinformatics services to various federal agencies, including the USDA, NIH, FDA, NOAA,...
This firm-fixed-price purchase order was awarded to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business based in Fremont, California. The $128,250.00 contract, awarded by the National Institute on Aging (part of the National Institutes of Health), is for whole genome sequencing services in support of the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) study. Seqmatic has secured numerous federal contracts supporting scientific research...

This federal contract award is for the purchase of Next Generation Sequencing (NGS) RNA reagents tests by the Food and Drug Administration (FDA). The $99,900.00 firm-fixed price contract was awarded to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business based in Fremont, California. Seqmatic specializes in genomics and bioinformatics services, and has secured numerous federal contracts with civilian agencies.

The work under this contract will involve comprehensive genomic services, including quality control checks of RNA samples, total RNA sequencing using the NovaSeq X Plus platform, and data analysis to identify changes in both coding and noncoding RNAs in primary human hepatocytes following drug treatment. This contract is not set aside and is open to full and open competition. Seqmatic is also the prime contractor on a larger $150 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the National Cancer Institute to provide genome characterization services in support of cancer research initiatives.

Generated 9/5/25, 9:52 AM